Is onxol the same as taxol?

Is Onxol the same as Taxol?

Onxol is a brand name for paclitaxel, the same active ingredient in Taxol. Both treat several types of cancer, including breast, ovarian, and lung cancer. They work by stopping cells from dividing during mitosis.

How does Onxol differ from Taxol?

Taxol is the original reference product developed by Bristol-Myers Squibb. Onxol came later as a generic version made by Ivax Pharmaceuticals. The formulations contain the same dose of paclitaxel, but minor differences in inactive ingredients may exist.

Can patients switch between Onxol and Taxol?

Doctors prescribe both interchangeably in clinical practice. Bioequivalence studies show they deliver comparable amounts of paclitaxel into the body. Switching does not require new dose calculations.

When did the Taxol patent expire?

Taxol's compound patent expired in 2000. The formulation patent for the cremophor-based solvent system expired in 2002. After these dates, multiple generic paclitaxel products, including Onxol, entered the market.

What price difference exists between Onxol and Taxol?

Taxol remains higher priced as a brand-name product. Onxol offers a cheaper alternative once generic entry occurred. Current pricing varies by pharmacy, dosage, and insurance coverage.

Who makes Taxol and Onxol?

Bristol-Myers Squibb originally developed Taxol. Ivax Pharmaceuticals produced Onxol. Later acquisitions placed Onxol under the control of Teva Pharmaceuticals.

What side effects are patients asking about?

Both products share the same main side effects: hair loss, low blood counts, nerve damage, and hypersensitivity reactions. Patients report allergic reactions to the cremophor solvent in both versions.